Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine the efficacy and safety of a three time repeated loading dose of intravenous ibandronate (ibandronic acid), 6 mg, in breast cancer patients with painful skeletal metastases.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Turku
• Collaborator: Hoffmann-La Roche
• Treatments: Ibandronic Acid

Criteria

Inclusion Criteria:

• Breast cancer with presence of bone metastases

• Pain score over 4 on the VAS

Exclusion Criteria:

• Patients with pathological fractures or medulla compression or neuropathic pain

• Patients with infection or corticosteroid treatment

• Pregnant or lactating patients